The use of COA in patient-centered drug development: part 2
COA in PROgress
00:00
Introduction
Exploring the payer and health technology agency landscape for patient reported outcomes, discussing guidance documents, regulatory perspectives, and insights from experts in the field.
Play episode from 00:00
Transcript
